Novartis acquired Anthos Therapeutics from Blackstone for $3.1 billion
Novartis, the Swiss pharmaceutical giant, has agreed to pay up to $3.1 billion for Anthos Therapeutics, a biopharmaceutical company majority-owned...
abelacimab
Novartis, the Swiss pharmaceutical giant, has agreed to pay up to $3.1 billion for Anthos Therapeutics, a biopharmaceutical company majority-owned...
